Skip to main content
Premium Trial:

Request an Annual Quote

Consolidation History in the Bioinformatics Sector, as Tracked by BioInform, 2003

Premium

January: Structural Genomics, GeneFormatics announce plans to merge (relaunch as Cengent Therapeutics in May)

February: Viaken Systems closes

February: Phase-it acquired by Europroteome

March: Molecular Mining closes (former employees license technology and launch Predictive Patterns in June)

April: Argentys (formerly Blackstone) acquired by TurboWorx

April: LabBook discontinues retail operations; Rescentris licenses technology

June: AnVil closes

June: Molecular Ware acquired by CalbaTech

August: Physiome Sciences acquired by Predix Pharmaceuticals (former Physiome employees license technology and launch the BioAnalytics Group in October)

September: Time Logic acquired by Active Motif

September: Incellico’s assets acquired by Genstruct

November: Celltech closes Confirmant database business (picked up via OGS acquisition in May)

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.